Drug misuse and dependency

Services

Drugs Test 1 (DT1) form
Form for the testing of specified class A drugs on persons ages 18 or over.
NDTMS: community combined review forms
Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
NDTMS: secure setting outcomes forms
Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

Controlled drugs list
- Guidance
- 8 August 2022
- Home Office
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
Drug strategy housing support funding: allocations 2022 to 2025
- Guidance
- 3 February 2023
- Office for Health Improvement and Disparities
Extra funding for drug and alcohol treatment: 2022 to 2023
- Guidance
- 13 April 2022
- Office for Health Improvement and Disparities
FRANK: free practical drug advice for adults and children
- Guidance
- 8 April 2013
- Home Office

ACMD Nitrous Oxide: public call for evidence
- 8 February 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence
Synthetic opioids will be banned as government acts to stop drug deaths
- 3 February 2023
- Home Office
- News story
£53 million cash boost to improve housing support for drug and alcohol recovery
- 3 February 2023
- Department of Health and Social Care and Department for Levelling Up, Housing and Communities
- Press release
£3.6 million social prescribing funding for mental health support
- 23 December 2022
- Department of Health and Social Care and Department for Digital, Culture, Media & Sport
- Press release
Barriers to research with synthetic cannabinoid receptor agonists
- 12 December 2022
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence

Substance misuse treatment for young people: statistics 2021 to 2022
- 2 February 2023
- Office for Health Improvement and Disparities
- National statistics
Substance misuse treatment for adults: statistics 2021 to 2022
- 19 January 2023
- Office for Health Improvement and Disparities
- National statistics
Synthetic cannabinoid receptor agonists
- 6 December 2022
- Advisory Council on the Misuse of Drugs
- Research
People who inject drugs: HIV and viral hepatitis monitoring
- 11 August 2022
- UK Health Security Agency
- Research
ACMD Naloxone Review
- 17 June 2022
- Advisory Council on the Misuse of Drugs
- Research

Expanding access to naloxone
- 15 March 2022
- Department of Health and Social Care
- Closed consultation
- Date closed 28 September 2021
Independent review of drugs: call for evidence, part 2
- 2 July 2020
- Department of Health and Social Care
- Closed consultation
- Date closed 07 August 2020
NDTMS annual reports and methodology: proposed changes
- 24 September 2019
- Closed organisation: Public Health England
- Consultation outcome
- Date closed 25 August 2019
From harm to hope: A 10-year drugs plan to cut crime and save lives
- 29 April 2022
- Home Office, Department of Health and Social Care, Ministry of Justice, Department for Work and Pensions, Department for Education, and Department for Levelling Up, Housing and Communities
- Policy paper
ACMD ageing cohort of drug users report: government response
- 3 October 2019
- Department of Health and Social Care
- Policy paper

Rough sleeping drug and alcohol treatment grant: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Doctor licensing for diamorphine prescribing: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Individual Placement and Support (IPS-AD) trial: privacy notice
- 28 January 2022
- Office for Health Improvement and Disparities
- Corporate report
UK government Drug Recovery Champion annual report
- 9 December 2021
- Home Office
- Corporate report
Standard Operating Procedure for using evidence in ACMD reports
- 4 May 2021
- Advisory Council on the Misuse of Drugs
- Corporate report

Show more organisations